New Preclinical Testing Tools Help Researchers Tailor Treatment but Can They Fully Replace Mice?
Premium
Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, while others remain skeptical.
Precision oncology company Inocras launched a clinical MRD test last week that uses Ultima's platform to sequence circulating tumor DNA from blood.
FDA Approves Verastem's Avmapki, Fakzynja Combo for KRAS-Mutant Ovarian Cancer Patients
The agency approved the treatment based on data from 57 patients with previously treated KRAS-mutant recurrent low-grade serous ovarian cancer.
Haya Therapeutics Raises $65M in Series A Funds to Develop Noncoding RNA-Targeted Drugs
The firm develops RNA-guided therapeutics that target the regulatory genome, composed of genes that regulate expression of other genes.
Sangamo Therapeutics Sets Sights on 2026 BLA Filing for Fabry Disease Gene Therapy
A "productive" meeting with the FDA has given the firm confidence in its regulatory filing and commercialization plans for ST-920.